Mitech엠아이텍
179290 · KOSDAQ · ₩179290 · 엠아이텍
- Market cap
- ₩134B
- Enterprise value
- ₩100B
- P/E
- 6.4×
- P/B
- 1.0×
- Dividend yield
- 2.9%
- ROE
- 15.6%
- Net margin
- 29.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−47.5% from the high
₩3,985Today: ₩4,065 – ₩4,175₩7,860
Returns
- 1W−11.7%
- 1M−8.6%
- 3M−8.5%
- 6M−38.2%
- YTD−39.0%
- 1Y−37.4%
- Volume today
- 59,307
- 1.0× the 20-day average
- Traded today
- ₩243M
- Listed shares
- 32,365,678
- EPS (12 months)
- ₩640
- Earnings yield 15.5%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumWeak-8.7% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Mitech stock overview
Mitech (엠아이텍, KRX: 179290) is listed on KOSDAQ, in the Medical & precision devices sector. MI-Tech develops, manufactures and sells non-vascular stents for gastroenterology, the first of their kind developed in Korea, and exports them to major overseas markets. Its shares closed at ₩4,130 on Oct 27, 2026, down 0.72% on the day, giving it a market value of ₩134B.
Key facts
- Market cap
- ₩134B
- Sector
- Medical & precision devices
- Latest price change
- −0.72%
- As of
- Oct 27, 2026
- Main business
- MI-Tech develops, manufactures and sells non-vascular stents for gastroenterology, the first of their kind developed in Korea, and exports them to major overseas markets.
Quick answers about Mitech
- What does Mitech do?
- MI-Tech develops, manufactures and sells non-vascular stents for gastroenterology, the first of their kind developed in Korea, and exports them to major overseas markets. Its products, made with a precision process that includes manual steps, are customized and are increasingly used beyond malignant tumors to benign conditions; it also sells veterinary stents and distributes Fujifilm endoscopy equipment in South Korea since 2020. The company operates from its plant in Pyeongtaek, Gyeonggi-do, and is building a production facility in Ho Chi Minh City, Vietnam.
- What is the market cap of Mitech?
- The market capitalisation of Mitech was ₩134B at the close on Oct 27, 2026.
- Who are the largest shareholders of Mitech?
- According to the latest official filings, the largest reported holders are Synergy Innovation (53.09%, as of Apr 2, 2026); Cho Yoon-ha (4.59%, as of Feb 26, 2026); National Pension Service (0.53%, as of Dec 31, 2024).
- When is the next earnings report from Mitech?
- Korean companies rarely announce results dates in advance. Based on when Mitech filed the same report in past years, its next 3q results is expected between Nov 12, 2026 and Nov 14, 2026.
- Does the National Pension Service own Mitech?
- Yes. The National Pension Service held 0.53% of Mitech shares as of Dec 31, 2024.
Company profile
MI-Tech develops, manufactures and sells non-vascular stents for gastroenterology, the first of their kind developed in Korea, and exports them to major overseas markets. Its products, made with a precision process that includes manual steps, are customized and are increasingly used beyond malignant tumors to benign conditions; it also sells veterinary stents and distributes Fujifilm endoscopy equipment in South Korea since 2020. The company operates from its plant in Pyeongtaek, Gyeonggi-do, and is building a production facility in Ho Chi Minh City, Vietnam.
Written by AI from the company's latest annual report.
- Korean name
- 엠아이텍
- Themes
- Medical devices
- CEO
- 곽재오
- Founded
- Apr 1991
- Listed
- Nov 2018
- Listed shares
- 32,365,678
- Fiscal year ends
- Month 12
- Website
- www.mitech.co.kr
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Amended: Acquisition of shares in another companySep 28, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Acquisition of shares in another companyJul 27, 2026
- Quarterly report (Mar 2026)May 13, 2026
- Amended: Cash dividend decisionApr 21, 2026
Titles in Korean until English translations are added.
Also known as: Mitech / 엠아이텍 / 179290 / KRX:179290
Source: KRX statistical information